• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Invivyd, Inc. - Common Stock (NQ: IVVD )

    2.220 +0.140 (+6.73%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 997,671
    Open 2.220
    Bid (Size) 2.220 (3)
    Ask (Size) 2.400 (2)
    Prev. Close 2.080
    Today's Range 2.070 - 2.275
    52wk Range 0.9802 - 5.195
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position
    From Invivyd
    Via GlobeNewswire
    Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
    From Invivyd
    Via GlobeNewswire

    Performance

    YTD
    -39.18%
    -39.18%
    1 Month
    -47.76%
    -47.76%
    3 Month
    -55.78%
    -55.78%
    6 Month
    +37.04%
    +37.04%
    1 Year
    +79.03%
    +79.03%

    More News

    Read More
    Invivyd Announces CEO Transition
    From Invivyd
    Via GlobeNewswire
    IVVD Stock Earnings: Invivyd Misses EPS for Q4 2023
    Via InvestorPlace
    Invivyd: Q4 Earnings Insights
    Via Benzinga
    Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
    From Invivyd
    Via GlobeNewswire
    Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
    From Invivyd
    Via GlobeNewswire
    Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    FDA Gives Emergency Use Nod To Invivyd's Antibody To Prevent COVID-19 Infection In Adults, Adolescents With Weak Immune System
    Via Benzinga
    Exposures COVID-19 Product Safety
    Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial
    From Invivyd
    Via GlobeNewswire
    Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
    From Invivyd
    Via GlobeNewswire
    Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    From Invivyd
    Via GlobeNewswire
    3 Groundbreaking Biotech Stocks to Invest in Now
    Via InvestorPlace
    Apple To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and Adolescents
    From Invivyd
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.